We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNNT
301
Pennant Park Investment Corp
PNNT
$215M
| $53.4K | 0.01% |
7,115
-989
| -12% | -$7.43K |
|
302
Acuity Brands
AYI
$9.88B
| $52.9K | 0.01% |
+309
| New | +$57.6K |
|
303
Denison Mines
DNN
$2.63B
| $52.3K | 0.01% |
112,224
| – | – |
|
|
PAY
304
DELISTED
Verifone Systems Inc
PAY
| $52.1K | 0.01% |
2,574
-327
| -11% | -$6.38K |
|
305
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
| $52K | 0.01% |
950
-3,847
| -80% | -$202K |
|
|
GAP
306
The Gap Inc
GAP
$6.84B
| $50.3K | 0.01% |
1,702
+279
| +20% | +$6.86K |
|
307
Neurocrine Biosciences
NBIX
$17.7B
| $49.3K | 0.01% |
+805
| New | +$42.5K |
|
308
Bread Financial
BFH
$4.21B
| $49K | 0.01% |
277
-39
| -12% | -$7.24K |
|
309
PUT
Kinross Gold
KGC
$28.5B
| $48K | 0.01% |
2,000
| – | – |
|
310
Sabesp
SBS
$19.7B
| $47K | 0.01% |
23,163
+9,323
| +67% | +$18.8K |
|
311
Accenture
ACN
$89.9B
| $46.3K | 0.01% |
+343
| New | +$44.7K |
|
312
CVS Health
CVS
$137B
| $46K | 0.01% |
566
-1,961
| -78% | -$155K |
|
313
Canadian National Railway
CNI
$78.3B
| $45.3K | 0.01% |
545
| – | – |
|
314
VEON
VEON
$3.53B
| $44.8K | 0.01% |
428
| – | – |
|
|
AABA
315
DELISTED
Altaba Inc
AABA
| $43.9K | 0.01% |
+663
| New | +$40.7K |
|
316
Occidental Petroleum
OXY
$57B
| $43.8K | 0.01% |
683
+71
| +12% | +$4.32K |
|
|
NBL
317
DELISTED
Noble Energy, Inc.
NBL
| $43.5K | 0.01% |
1,534
+177
| +13% | +$4.66K |
|
318
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$98.7M
| $43K | 0.01% |
589
| – | – |
|
|
GAU
319
Galiano Gold
GAU
$486M
| $42.7K | 0.01% |
45,000
| – | – |
|
|
NFX
320
DELISTED
Newfield Exploration
NFX
| $42.7K | 0.01% |
1,438
+161
| +13% | +$4.32K |
|
|
JNPR
321
DELISTED
Juniper Networks
JNPR
| $41.5K | 0.01% |
1,490
+384
| +35% | +$10.8K |
|
322
iShares Biotechnology ETF
IBB
$9.31B
| $40.7K | 0.01% |
366
-33
| -8% | -$3.53K |
|
|
ALXN
323
DELISTED
Alexion Pharmaceuticals
ALXN
| $39.6K | 0.01% |
+282
| New | +$38.3K |
|
324
Molson Coors Class B
TAP
$7.68B
| $39.5K | 0.01% |
484
-227
| -32% | -$20K |
|
325
Cognizant
CTSH
$21.5B
| $38.9K | 0.01% |
536
-93
| -15% | -$6.53K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.